The future outlook on allergen immunotherapy in children: 2018 and beyond
The future outlook on allergen immunotherapy in children: 2018 and beyond
About this item
Full title
Author / Creator
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
Allergen immunotherapy (AIT) is the only currently available immune-modifying and aetiological treatment for patients suffering from IgE-mediated diseases. In childhood, it represents a suitable therapeutic option to intervene during the early phases of respiratory allergic diseases such as rhino-conjunctivitis and asthma, which is when their progr...
Alternative Titles
Full title
The future outlook on allergen immunotherapy in children: 2018 and beyond
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_31b3779a8f99474f93542267e92cbfe0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_31b3779a8f99474f93542267e92cbfe0
Other Identifiers
ISSN
1824-7288,1720-8424
E-ISSN
1824-7288
DOI
10.1186/s13052-018-0519-4
